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SCORPION STINGS IN TURKEY: EPIDEMIOLOGICAL AND CLINICAL ASPECTS BETWEEN THE 
YEARS 1995 AND 2004 
Yıldırım CESARETLI(1) & Ozcan OZKAN(1) 
SUMMARY
The most important health-threatening scorpions found in Turkey are; Androctonus crassicauda, Leiurus quinquestriatus, 
Mesobuthus gibbosus and M. eupeus species, all of which belong to the Buthidae family. The epidemiological and clinical findings of 
scorpion stings in Turkey were evaluated between the years 1995 and 2004 based on data recorded in the National Poison Information 
Center (NPIC). A total of 930 cases were recorded. The cases mostly occurred in the month of July. The gender distribution was 
50.22% female and 45.48% male. It was shown that the 20-29 age group presented more scorpion stings. Most of the stings occurred 
in Central Anatolia and Marmara regions of Turkey. Patients at the hospital showed signs of localized (pain, hyperemia, edema and 
numbness) and systemic effects (hyperthermia, nausea and vomiting, tachycardia, shivering and lethargy) but no lethality was notified. 
According to records, 33% of the poisoned patients were treated with antivenin in healthcare facilities.
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INTRODUCTION
Scorpions contain concentrates of biologically active substances 
developed to block vital physiological and biochemical functions of the 
victim. Scorpion poisoning is a life-threatening emergency and causes 
serious health problems in tropical and subtropical regions, especially in 
north Africa, Latin America, India, and the middle East. Clinical reports 
of victims stung by scorpions describe cardiac dysfunction and respiratory 
failure that can be fatal2,17,26,34.
Different approaches to the treatment of scorpion poisoning have 
been advocated by different investigators. Some of them recommend 
treatment of mild cases of poisoning with symptomatic measures and/
or antivenin20 and severe cases with symptomatic measures, support of 
vital functions and IV injection of antivenin2,20. 
Epidemiologic data are scarce due to under-declaration of cases and 
the insufficiency of studies devoted to scorpion stings. Two factors may 
explain the deficiency of information: the generally reduced severity of 
scorpion poisoning in adults, and the organization of health services, 
which do not require very precise information8. Therefore, the national 
poison information services or centers have an important role to pay 
attention to physicians or patients in case of scorpion poisoning. In 
Turkey, the National Poison Information Center (NPIC) was established 
in the Refik Saydam Public Health Agency (RSPHA) of the Ministry of 
Health (http://uzem.rshm.gov.tr) in 1986. It works 24 hours a day, having 
done so since 1988.
The aim of this study was to classify and characterize scorpion stings 
among inquiries to the National Poison Information Center between 
the years 1995 and 2004, in regard to the epidemiology and clinical 
symptomatology. 
PATIENTS AND METHODS
Data collection: The NPIC was established in 1986 and is accessible 
on a 24/7 basis. Clinicians in Turkey encountering victims of scorpion 
poisoning are required to report the cases to the NPIC. For this study, 
only cases involving scorpion poisoning in the NPIC database between 
the years 1995 and 2004 were investigated. 
Epidemiological and clinical data: Clinical and epidemiological 
data were obtained from the NPIC database. The data were evaluated 
according to the patients’ age, gender, day of sting, admission to the 
healthcare facility, clinical symptoms (localized and systemic) and 
condition of the patients and treatment. 
Clinical assessment of poisoning and treatment: Clinical 
assessment of all registered cases was conducted based on recorded 
occurrences submitted by local physicians. Patients were classified into 
two major groups based on observed symptoms. The localized signs 
group had symptoms including localized pain hyperemia, burning and 
itching. The systemic signs group had symptoms that are outlined in 
Table 2. Patients were further divided by the health professionals into 
those with either no, mild, moderate, or severe poisoning, according to 
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the clinical features. Mild poisoning was characterized by localized signs 
(pain, edema), and localized sweating; moderate poisoning by localized 
signs, and systemic poisoning (manifestations such as sialorrhea, 
sweating, nausea, vomiting, abdominal pain, tachycardia, tachypnea, 
mild hypertension, agitation, drowsiness), and severe poisoning was 
characterized, besides the moderate signs, by stupor or coma.
Statistical analysis: Data of patients were analyzed with SPSS 
software, using the Pearson’s chi-square method. Values obtained were 
considered to be significantly different if p < 0.05.
RESULTS
We compiled all cases reported in Turkey of human scorpion stings 
between 1995 and 2004. Among the gross total of reported poisoning 
cases of various origin (129,548), 1,929 (1.5%) of all incidents involved 
animal bites and stings, of which 930 (48.2%) were scorpion stings. 
Epidemiological data: The accidents occurred in all regions of 
Turkey. The majority of the incidents happened in the Central Anatolia 
region and in the Marmara region (Fig 1).
Most of the cases (54.95%) were notified during the summer period, 
as shown in Fig 2. The monthly distribution of cases of scorpion stings 
was 14.95% in May, 14.95% in June, 20.43% in July, 19.57% in August 
and 12.37% in September (i.e. mainly distributed between the months 
of May and September), with a peak in July (Fig. 2).
The gender distribution of the victims is 50.22% female and 45.48% 
male. Scorpion stings also have been mostly seen in male patients between 
Fig. 1 - Distribution of scorpion stings according to geographic regions of Turkey. Health professionals did not identify the scorpion species causing the poisoning in patients. However, 
important scorpion species threatening public health in Turkey are identified as Androcronus crassicauda, Leiurus quinquestratus (Southeastern and Eastern Anatolia regions), Mesobuthus 
gibbosus (Aegean, Mediterranean, Marmara and Central Anatolia regions), M. eupeus (Southeastern, Eastern and Central Anatolia regions) of Buthidae family. The majority of scorpion sting 
cases were in the Central Anatolia region and the Marmara region.
Fig. 2 - Distribution of scorpion stings according to months and seasons.
0-19 age groups. On the other hand, female were more liable to scorpion 
sting than men, in patients aged 20 and over. There was a statistically 
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significant association between age groups and sexes (p < 0.01). The age 
distribution of the patients is displayed in Table 1. With respect to the 
age, it is shown that the 20-29 age group presented more scorpion stings 
(23.55%) than the other groups. The notification records indicated that 
most of the stung patients arrived at the hospital in a time ranging between 
one to three hours after the sting (89.39% of the patients) (Table 1).
Clinical assessment of the poisoning and treatment: The most 
common symptoms of scorpion sting are shown in Table 2. Scorpion 
stings caused both localized and systemic effects. Localized symptoms 
were observed in 77.93% of the cases, as localized pain (47.58%), 
Table 1
Epidemiological characteristics of patients stung by scorpions
EPIDEMIOLOGICAL CHARACTERISTICS
Gender Number of patients 
(n: 930)
Age (Year) Male Female Unknown TOTAL %
 ≤ 4 63 52 16 131 14.09
5-9 56 52 3 111 11.94
10-19 99 76 - 175 18.82
20-29 93 123 3 219 23.55
30-39 56 71 1 128 13.76
40-49 29 36 1 66 7.10
50-59 5 24 - 29 3.11
60-69 14 21 - 35 3.76
≥ 70 5 3 - 8 0.86
Unknown 3 9 16 28 3.01
TOTAL 423 467 40 930 100
% 45.48 50.22 4.30
Pregnancy (n:19)
Trimester I 2 10.52
Trimester II 8 42.11
Trimester III 9 47.37
Time elapsed until admission (h) [n: 253]
< 1 71 28.06
1-3 143 56.52
4-6 18 7.12
7-24 17 6.72
> 24 4 1.58
Admission center
Local hospital 831 89.36
Private medical center 84 9.03
Primary health center 7 0.75
Others 8 0.86
Table 2 
The register is a database of all cases of scorpion stings according to symptoms 
of poisoning and frequency of the clinical symptoms reported in each incidence 
of poisoning. The records of healthcare organizations have shown localized 
(77.9%) and systemic symptoms (22%) in the cases (145 out of 930). In 
addition, 177 out of all cases of scorpion stings were also classified as no, mild, 
moderate, and severe poisoning, by health professionals
Clinic symptoms Number of patients 
(n: 145)
(%)
Local symptoms 113 77.93
Pain 69 47.58
Hyperemia 35 24.14
Edema 34 23.45
Numbness 9 6.21
Burning 2 1.38
Itching 1 0.69
Induration 1 0.69
Systemic symptoms 32 22.07
Nausea 7 4.82
Tachycardia 4 2.76
Vomiting 4 2.76
Tremor 4 2.76
Hyperthermia 3 2.07
Lethargy 3 2.07
Hypertension 2 1.38
Bradycardia 2 1.38
Hypotension 2 1.38
Agitation 2 1.38
Sweating 2 1.38
Spasm 2 1.38
Loss of consciousness 2 1.38
Pulmonary infusion 1 0.69
Chest pain 1 0.69
Abdominal pain 1 0.69
Sialorrhea 1 0.69
Stupor 1 0.69
Abdominal distention 1 0.69
Fasciculation 1 0.69
Confusion 1 0.69
Convulsion 1 0.69
Feel cold 1 0.69
Clinical assessment of envenoming (n: 177)
No envenomation 2 1.13
Mild envenomation 60 33.90
Moderate envenomation 107 60.45
Severe envenomation 8 4.52
Treatment (n: 103)
Symptomatic 60 58.25
Symptomatic and antivenom 9 8.75
Antivenom 34 33.00
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hyperemia (24.14%), edema (23.45%) and numbness (6.21%). When 
we evaluated systemic symptoms observed in scorpion stings, the 
most frequent findings we noted in descending order are: nausea 
(4.82%), tachycardia, vomiting and shivering (2.76%), hyperthermia 
and lethargy (2.07%). In addition, the highest rate of poisoning was 
clinically classified as moderate (60.45%), followed by mild (33.90%), 
according to notifications by the health professionals, as shown in Table 
2. The data showed us that 58.25% of the stung persons were treated 
symptomatically, 8.75% symptomatically and with antivenin, and finally, 
33% with antivenin in healthcare facilities. 
DISCUSSION
According to recent study, north-Saharan Africa, Sahelian Africa, 
South Africa, Near and Middle-East, South India, Mexico and South 
America, east of the Andes areas involve an at risk population of 2.3 
billion, which 1.2 million leading to more than 3250 deaths. Therefore, 
scorpion poisoning cases are still a considerable public health problem 
in all regions of the country8.
There have been only few epidemiological records, instances of 
clinical research and case reports on Mesobuthus eupeus, Androctonus 
crassicauda scorpion stings and scorpion stings in children in the West 
and southeastern parts of Turkey3,6,7,23,27,28,36. There is also only one study 
about the general scorpion sting incidence covering all geographical 
regions of Turkey29. However, as far as we know, the present is the first 
epidemiological and clinical study on scorpions and scorpion stings 
covering all geographical regions of Turkey. 
In this study, a retrospective analysis of poisoning incidences 
recorded in NPIC showed us a total number of 930 inquiries related to 
scorpion stings within a period of ten years (1995-2004). Recently in 
a study, a total number of 24,261 scorpion sting cases were reported 
to have occurred in 2005, most of which occurred in the Southeastern 
Anatolia, Mediterranean Sea and Aegean regions29. In our study, most 
scorpion stings were notified in the Central Anatolia region and in the 
Marmara region. Our results suggest that medical professionals have more 
knowledge and experience regarding the treatment of scorpion stings in 
Southeastern Anatolia, Mediterranean Sea, and Aegean regions because 
most of the cases occurred in these areas. 
In Morocco, the majority of victims (91.4%) arrived at the hospital 
in less than three hours after the accident37. In another study, in Saudi 
Arabia22, the majority of cases were reported in primary health care 
centers (85.5%) and hospitals (10.50%). However, in the present study, 
89.39% of patients attended local hospitals within three hours (84.58%) 
of the sting. The reason for this is considered to be that the people of 
the region know what to do and immediately look for the treatment of 
scorpion sting, because they have more experience of scorpion stings.
In warm climates, scorpions become more active. Therefore, the 
highest incidence of scorpion stings took place in the warmest months 
of the year in different countries such as Iran33,35, Mexico9,11,25, Morocco1, 
Egypt16, Argentina13, Saudi Arabia21, Brazil30 and Turkey7,29. In parallel, 
we found that scorpion stings are frequent during hot months (May-
September), with a maximum frequency in July. 
In Mexico, Saudi Arabia and Argentina, epidemiological studies 
showed that most scorpion stings were seen in males9,13,21. In our study, 
scorpion stings were seen mostly in females (50.22%). However, the 
most scorpion stings were seen in males in the 0-19 age group. The ratio 
between age groups and gender was statistically significant (p < 0.01). 
JARRAR & AL-ROWAILY22 stated that the majority of scorpion stings 
occurred in people aged between 20 and 29 years old, during work. They 
explained that this result is associated with outdoor activities. Our study 
has similar results. The reason for this is considered to be the fact that 
the young population in this region work in agricultural fields during 
the summer period. In Morocco, the highest sting incidence reported, 
60%, involved victims younger than 30 years old37,38. Another study on 
scorpion stings in Mexico reported that 77% of all accidents occurred 
among people younger than 30 years old12. In this study, similar results 
have been found for the same age group. 
Important scorpion species threatening public health in Turkey 
are identified as Androcronus crassicauda, Leiurus quinquestratus, 
Mesobuthus gibousus and M. eupeus of the Buthidae family27-29. The 
venom of the Buthidae family has neurotoxic effects. The neurotoxic 
peptides in the venom are responsible for the symptoms that present 
during poisoning, by interacting with ion channels. Ion channels are gated 
pores of which gating may be intrinsic or regulated by ligand binding 
or changes in the voltage gradient across the membrane15. Localized or 
systemic clinical effects could appear related to the species of scorpion, 
feeding state, structure of the telson and amount of venom injected, 
number of stings, time of admission to hospital, sensitivity of patient, 
age, weight and climate of the region13,14,18,33.
According to literature on the clinical and epidemiological aspects 
of scorpion stings in Turkey, poisoning was characterized by localized 
and systemic symptoms. The most common symptoms reported were 
localized pain, edema, hyperemia, swelling, burning, numbness and 
itching, and the systemic symptoms were a dry mouth, thirst, sweating, 
hypotension, hypertension, cramps and shivering, nausea, vomiting, 
difficulty in breathing, tachycardia, sialorrhoea, restlessness, hemolytic-
uremic syndrome, cyanosis, cardiac failure and/or acute pulmonary edema 
and death3,6,7,10,23,24,27,28,31,36. 
Scorpion stings can cause similar clinic manifestations in many 
countries of Central and South America, North Africa, the Middle 
East and Asia5,9,13,21,30,37,38. In our study, the most common symptoms 
reported were: localized pain (47.58%), hyperemia (24.14%), edema 
(23.45%) and numbness (6.21%). Nausea (4.82%), tachycardia, 
vomiting and shivering (2.76%), hyperthermia and lethargy (2.07%) 
were also observed as systemic symptoms. In our research, cases (177 
out of 930) were also classified as mild (33.9%), moderate (60.45%), 
and severe poisoning (4.52%). In agreement with SHAHBAZZADEH 
et al.35 and CHOWELL et al.9 we observed most cases of poisoning 
as mild and moderate.
The only specific treatment for scorpion poisoning is the species-
specific antivenin. Antivenin is widely used in cases of scorpion stings. 
However, its efficacy is still controversial, particularly in the case of mild 
and moderate poisoning, although allergic reactions have never been 
reported2,4,18-20,32. In Turkey, the Refik Saydam Public Health Agency 
is responsible for the manufacturing of antivenin produced from A. 
crassicauda venom. This antivenin has been used for the treatment of 
all scorpion sting cases in Turkey3. In the present study, most of the 
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patients (58%) were treated symptomatically, whereas only 33% of the 
cases were treated with antivenin. 
In conclusion, we reported on the epidemiological and clinical 
characteristics of scorpion poisoning throughout the country of Turkey 
during the period 1995-2004. We argue that in Turkey, public awareness 
campaigns and an increase in the number of healthcare facilities and 
health care professionals have kept lethalities due to poisoning to a 
minimum. All scorpion species with highly potent, mammal specific 
neurotoxins belong to the family Buthidae, which therefore has medical 
importance. Nevertheless, identifying the scorpion may be considered as 
a useful clinical and epidemiological tool in determining the incidence 
and risk of scorpion poisoning. Of course, it will be important to supply 
sufficient quality and quantity of antivenin to medical facilities in both 
rural and urban areas and to maintain a critical number of trained medical 
professionals in the regions where poisoning is seen.
RESUMO
Picadas de escorpião na Turquia: aspectos epidemiológicos e 
clínicos entre os anos de 1995 e 2004
Os mais importantes escorpiões que comprometem a saúde na Turquia 
são: Androctonus crassicauda, Leiurus quinquestriatus, Mesobuthus 
gibbosus e M. eupeus, todos eles pertencentes à família Buthidae. Os 
achados clínicos e epidemiológicos da picada de escorpiões na Turquia 
foram avaliados no período entre os anos de 1995 a 2004 baseados 
em dados do Centro Nacional de Informações de Envenenamentos 
(NPIC). Foram registrados 930 casos que ocorreram principalmente no 
mês de julho. A distribuição por sexo foi 50,22% femininos e 45,48% 
masculinos. Demonstrou-se que o grupo etário de 20 a 29 anos apresentou 
maior número de picadas de escorpião. A maior parte das picadas 
ocorreu na Anatólia Central e na região de Marmara, na Turquia. Os 
pacientes hospitalizados mostraram sinais localizados (dor, hiperemia, 
edema e confusão mental) e sistêmicos (hipertermia, náusea e vômitos, 
taquicardia, arrepios de frio e letargia), mas não houve notificação de 
letalidade. De acordo com os prontuários 33% dos pacientes foram 
tratados com antiveneno nas unidades de saúde. 
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